Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Coeptis Therapeutics Holdings (COEPW) Long-Term Debt Repayments (2022 - 2024)

Historic Long-Term Debt Repayments for Coeptis Therapeutics Holdings (COEPW) over the last 3 years, with Q4 2024 value amounting to $63469.0.

  • Coeptis Therapeutics Holdings' Long-Term Debt Repayments fell 8186.61% to $63469.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.6 million, marking a year-over-year increase of 2865.05%. This contributed to the annual value of $650969.0 for FY2024, which is 4685.97% down from last year.
  • According to the latest figures from Q4 2024, Coeptis Therapeutics Holdings' Long-Term Debt Repayments is $63469.0, which was down 8186.61% from $287500.0 recorded in Q1 2024.
  • Coeptis Therapeutics Holdings' Long-Term Debt Repayments' 5-year high stood at $2.1 million during Q4 2022, with a 5-year trough of $50000.0 in Q3 2022.
  • Moreover, its 3-year median value for Long-Term Debt Repayments was $287500.0 (2024), whereas its average is $570424.1.
  • Within the past 5 years, the most significant YoY rise in Coeptis Therapeutics Holdings' Long-Term Debt Repayments was 164999.8% (2023), while the steepest drop was 8346.71% (2023).
  • Over the past 3 years, Coeptis Therapeutics Holdings' Long-Term Debt Repayments (Quarter) stood at $2.1 million in 2022, then tumbled by 83.47% to $350001.0 in 2023, then tumbled by 81.87% to $63469.0 in 2024.
  • Its Long-Term Debt Repayments was $63469.0 in Q4 2024, compared to $287500.0 in Q1 2024 and $350001.0 in Q4 2023.